Trump Administration Includes Collins’ Phair Pricing Act in New Drug Pricing Rule
WASHINGTON—This week the Centers for Medicare and Medicaid Services released a proposed rule to lower prescription drug costs and increase transparency surrounding Medicare Parts C and D. Included in the proposal is the bulk of the Phair Pricing Act, which Rep. Doug Collins (R-Ga.) introduced in May 2018 to lower drug costs to Medicare patients at the point of sale.
“Too often, prescription drug middlemen use abusive reimbursement schemes to inflate patient prices and unfairly cripple community health care providers. I’ve seen how much this ultimately leaves communities with higher costs and less access to quality care. President Trump’s administration is taking an incredibly tangible step to ensure that patients at the counter feel the savings that middlemen claim to negotiate on their behalves but have often kept in their own coffers,” said Collins.